Related Links Educational Materials About Clinical Trials Clinical Trials Questions to Ask Your Doctor Drug Information from MedlinePlus

Alternate Title
Basic Trial Information
Trial Description
     Purpose
     Eligibility
     Treatment/Intervention
Trial Contact Information
Related Information
Registry Information

Alternate Title

Study of Molecular Genetic Lesions and Clinical Outcomes in Children With Acute Lymphoblastic Leukemia

Basic Trial Information

Phase	Type	Status	Age	Sponsor	Protocol IDs
No phase specified	Diagnostic	Completed	Children	NCI	COG-B969 CCG-B969, NCT00003291

Trial Description

Purpose:

The identification of gene mutations may allow doctors to better determine the prognosis of children with acute lymphoblastic leukemia.

This clinical trial is studying gene mutations to see if they are related to prognosis of cancer in children with acute lymphoblastic leukemia.

Eligibility:

Eligibility criteria include the following:

• Enrolled on clinical trial CCG-1922, CCG-1882, or CCG-1901
• For more information about the eligibility criteria for this trial, refer to the Health Professional version.

Final eligibility for a clinical trial is determined by the health professionals conducting the trial.

Treatment/Intervention:

Patients will have bone marrow samples collected and analyzed for specific genetic mutations. Patients will be followed for at least 3 years. Patients will not receive the results from genetic testing. Results will not influence a patient's treatment on the clinical trial.

Important:

For more details about this trial, refer to the Health Professional version of the trial summary.

If you are interested in participating in a clinical trial, contact your doctor for a referral or call a trial contact person listed below. You may see the same contact person listed at more than one site, however, if you call the number listed you can ask to speak to the study coordinator or person involved with the specific trial you are interested in. If you have questions about cancer or clinical trials, call the Cancer Information Service at 1-800-4-CANCER (1-800-422-6237). General information about clinical trials, including risks, benefits, and costs, can be found on NCI's Web site.

Trial Contact Information

Trial Lead Organizations

Children's Oncology Group

Ursula Kees, PhD, Protocol chair		Ph: 61-8-9489-7852

Related Information

PDQ® clinical trial CCG-1922
PDQ® clinical trial CCG-1882
PDQ® clinical trial CCG-1901

Registry Information
Official Title		Molecular Genetic Lesions and Clinical Outcome in Pediatric ALL Patients
Trial Start Date		1998-03-03
Registered in ClinicalTrials.gov		NCT00003291
Date Submitted to PDQ		1998-09-15
Information Last Verified		2004-02-11
NCI Grant/Contract Number		CA97452

Back to Top